PD1 blockers work best when used in the morning, suggests cancer chronotherapy trial

Nature Reviews Drug Discovery 2026

View at publisher

Authors: Asher Mullard

DOI: 10.1038/d41573-026-00025-5

Cited by: 1

Fields of Study & Subjects

Cancer Stress Anesthesia and Immune Response Economic and Financial Impacts of Cancer Cancer Immunotherapy and Biomarkers